Catherine Ronet

Ludwig Cancer Research — Switzerland

Medicine · Health Sciences

35h-index4.3kcitations88works90.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Research on Leishmaniasis Studies(34), Cancer Immunotherapy and Biomarkers(25), Immune Cell Function and Interaction(20), Trypanosoma species research and implications(17), Immunotherapy and Immune Responses(16)

Publications88 total

Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure
Nature Cancer·2025· 17 citedOpen Access
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Nature·2024· 164 citedOpen Access
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells
Nature Immunology·2023· 44 citedOpen Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Figure from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Data from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Figure from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Figure from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Data from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Figure from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Figure from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Supplementary Table from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
Data from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Nicolás Fasel(20), Stephen M. Beverley(15), Mary‐Anne Hartley(13), Pascal Launois(11), Fabienne Tacchini‐Cottier(10), Florence Prével(8), George Coukos(7), Haroun Zangger(7), Chantal Desponds(7), Patrik Castiglioni(7), Martin Mempel(6), Gabriel Gachelin(6), Pierre Couppié(6), Denarda Dangaj Laniti(5), Evripidis Lanitis(5), Melita Irving(5), Mélanie Revaz‐Breton(5), Lon‐Fye Lye(5), Sylvie Darche(5), F Kuhlmann(5)